While glutathione supplements are popular, they may cause side effects
Monte cares for patients in the ER and has done extensive studies on marijuana use
Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in patients with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, and since 2024 for cardiovascular risk reduction in patients with established cardiovascular disease and overweight or obesity
5 Division of Hospital Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA Correspondence: Rakesh Kumar, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA, 55905, Email [email protected] Abstract: Acetyl-l-carnitine (ALC) is increasingly recognized for its potential psychopharmacological mechanism and role in the treatment of mood disorders, particularly major depressive disorder (MDD) and bipolar disorder (BD)
It's a simple adjustment that makes a world of difference in protocol adherence and subject comfort
Early research and growing examples suggest that addressing both hormonal decline with MHT and metabolic changes with GLP-1 therapy could result in greater weight loss and metabolic improvements compared to either approach alone